Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 9

Review

Sodium–glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin–metformin

       
Total article views   HTML views PDF downloads Totals
13,595 Dovepress* 12,344+ 2,425 14,769
PubMed Central* 1,251 640 1,891
Totals 13,595 3,065 16,660
*Since 15 March 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar